VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Sep 17, 2024 12:32pm

54 Views

Post# 36227388

Olá de Lisboa! 🌞 Yesterday Angiopro GmbH

Ol de Lisboa! Yesterday, we had the pleasure of attending a highly anticipated presentation on Digital Variance Angiography with the Kinepict Health Ltd. Software at CIRSE. The insights into advanced imaging technology were truly inspiring, and we’re excited about the future of healthcare innovation!

We’re still here at the event and would love to meet with fellow attendees. Feel free to reach out—we’re looking forward to connecting and discussing how we can shape the future of medical technology together.

CIRSE2024 Kinepict HealthcareInnovation DVA Networking